HM71224, a selective Bruton’s tyrosine kinase inhibitor, attenuates the development of murine lupus

por Kim, Yu-Yon, Park, Ki Tae, Jang, Sun Young, Lee, Kyu Hang, Byun, Joo-Yun, Suh, Kwee Hyun, Lee, Young-Mi, Kim, Young Hoon, Hwang, Kwang Woo
Publicado 2017

Target modulation and pharmacokinetics/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection

por Byun, Joo-Yun, Koh, Yi T., Jang, Sun Young, Witcher, Jennifer W., Chan, Jason R., Pustilnik, Anna, Daniels, Mark J., Kim, Young Hoon, Suh, Kwee Hyun, Linnik, Matthew D., Lee, Young-Mi
Publicado 2021

HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis...

por Park, Jin Kyun, Byun, Joo-Yun, Park, Ji Ah, Kim, Yu-Yon, Lee, Ye Ji, Oh, Jeong In, Jang, Sun Young, Kim, Young Hoon, Song, Yeong Wook, Son, Jeewoong, Suh, Kwee Hyun, Lee, Young-Mi, Lee, Eun Bong
Publicado 2016